Biden administration appeals Texas court decision striking down free Obamacare coverage of preventive care

Biden administration appeals Texas court decision striking down free Obamacare coverage of preventive care


The Biden administration on Friday appealed a Texas federal judge’s decision to strike down free Obamacare coverage of preventive health-care services ranging from screenings for certain cancers and diabetes to HIV prevention drugs.

U.S. Judge Reed O’Connor of the U.S. Northern District Court of Texas on Thursday struck down an Obamacare mandate requiring most private insurance plans to cover certain types of health care recommended an independent panel of experts called the Preventive Services Task Force.

“Preventive care is an essential part of health care: it saves lives, saves families money, and improves our nation’s health,” said Kamara Jones, a Health and Human Services spokesperson, on Thursday evening after the judge’s ruling. “Actions that strip away this decade-old protection are backwards and wrong.” 

The case will now go to U.S. Fifth Circuit Court of Appeals. A majority of the judges on that court were appointed by Republican presidents.

HHS estimates that 150 million Americans benefited from the free screenings, counseling, medications and other forms of health care that prevent disease under the Obamacare requirements.

Lawrence Gostin, an expert on health law at Georgetown University, said most private insurance plans will probably continue to cover these services but charge copays and deductibles. Working class Americans will get hit the hardest and might forgo essential health care because they can’t afford the cost, Gostin said.

O’Connor ruled that Obamacare cannot mandate free coverage of health care recommended by the Preventive Services Task Force because the organization’s members were appointed in an illegal manner.

Here is a list of the preventive health services that the judge’s ruling likely applies to

Two business owners and several individuals sued the U.S. in March 2020 over the preventive health services mandate, arguing that buying insurance that covers drugs that prevent HIV infection violates their Christian religious beliefs.

The plaintiffs claimed in their suit that the mandate to cover HIV prevention drugs “forces religious employers to provide coverage for drugs that facilitate and encourage homosexual behavior, prostitution, sexual promiscuity, and intravenous drug use.”

They also argued the Preventive Services Task Force was appointed in an unconstitutional manner and therefore its recommendations cannot serve as the basis of an Obamacare mandate.

This is a developing story. Please check back for updates.

Join CNBC’s Healthy Returns on March 29th, where we’ll convene a virtual gathering of CEOs, scientists, investors and innovators in the health care space to reflect on the progress made today to reinvent the future of medicine. Plus, we’ll have an exclusive rundown of the best investment opportunities in biopharma, health-tech and managed care. Learn more and register today: 



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More